Congress
Both short-read and long-read instrument makers are fleshing out their multiomics menus as they hope to gain a share of the fast-evolving market.
House Passes Biosecure Act With Bipartisan Support
The torch to sanction certain targeted Chinese biotech firms is now passed to the Senate, which does not yet have a clear timeline for the vote.
Some researchers are struggling to grasp the bill's rationale for sanctioning Complete Genomics' products, which they do not believe pose data security risks.
New Biosecure Act Draft Proposes 2032 Deadline to Cease Activities with BGI, MGI, Affiliates
The new version of the legislation also added a five-year buffer period for new companies added to the so-called biotechnology companies of concern list.
Reports show Illumina spent close to $500,000 in the first quarter on lobbying efforts related in part to the Biosecure Act and the National Defense Authorization Act.